Satellos Bioscience Completes US$57.2 Million Cross-Border Public Offering and Nasdaq Listing

Leila Ahmed North America Legal Chronicle
Tagged:

Mintz has advised Satellos Bioscience Inc. Latham & Watkins has represented the underwriters. Satellos Bioscience Inc., a clinical-stage biotechnology company, has completed a US$57.2 million underwritten…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here